Improving HPV vaccination recommendations for young women with HIV in Malawi
Official title: Kupewa: Optimizing strategies to implement provider recommendation of HPV vaccination for adolescent girls and young women with HIV in Malawi
Funded at New York University · NIH-11001376 · Data updated 2026-11-12
This study is all about finding better ways to help young girls and women aged 9-24 living with HIV in Malawi get the HPV vaccine, which can help prevent cancer, by encouraging doctors to recommend it more often.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $612,499 |
| NIH project number | 1U01CA294756-01 |
| Project ID | NIH-11001376 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescent girls and young women aged 9-24 living with HIV in Malawi.
✕Less likely to help
Patients outside the age range of 9-24 or those not living with HIV may not benefit from this research.
What this research studies
This research focuses on enhancing the uptake of HPV vaccinations among adolescent girls and young women aged 9-24 living with HIV in Malawi. It aims to identify and optimize strategies that encourage healthcare providers to recommend the HPV vaccine, which is crucial for cancer prevention. By utilizing frameworks that address behavioral and social factors, the project seeks to implement effective recommendations and assess their sustainability over time. The ultimate goal is to improve vaccination rates in a resource-constrained setting where access to healthcare is limited.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among young women with HIV, leading to reduced cervical cancer incidence.
How similar studies have gone: Similar research has shown that clinician recommendations can effectively increase vaccination rates, suggesting a promising approach for this project.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Moucheraud, Corrina — New York University
- Study coordinator: Moucheraud, Corrina
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.